1. Desmoplastic melanoma: is there a role for sentinel lymph node biopsy?
- Author
-
Han D, Zager JS, Yu D, Zhao X, Walls B, Marzban SS, Rao NG, Sondak VK, and Messina JL
- Subjects
- Adolescent, Adult, Age Factors, Aged, Aged, 80 and over, Confidence Intervals, Disease-Free Survival, False Negative Reactions, Female, Follow-Up Studies, Humans, Kaplan-Meier Estimate, Lymph Nodes surgery, Lymphatic Metastasis, Male, Melanoma mortality, Middle Aged, Multivariate Analysis, Neoplasm Invasiveness, Odds Ratio, Predictive Value of Tests, Retrospective Studies, Skin Neoplasms mortality, Survival Rate, Young Adult, Lymph Nodes pathology, Melanoma secondary, Neoplasm Recurrence, Local pathology, Sentinel Lymph Node Biopsy, Skin Neoplasms pathology
- Abstract
Background: The utility of sentinel lymph node biopsy (SLNB) for desmoplastic melanoma (DM) is debated. We describe a large single-institution experience with SLNB for DM to determine clinicopathologic factors predictive of SLN metastasis., Methods: Retrospective review identified 205 patients with DM who underwent SLNB from 1992 to 2010. Clinicopathologic characteristics were correlated with SLN status and outcome., Results: Median age was 66 years, and 69 % of patients were male. Median Breslow thickness was 3.7 mm. In 128 cases (62 %), histologic subtype data was available; 61 cases (47.7 %) were mixed and 67 cases (52.3 %) were pure DM. A positive SLN was found in 28 cases (13.7 %); 24.6 % of mixed and 9 % of pure DM had SLN metastases. Multivariable analysis demonstrated that after controlling for age, histologic subtype correlated with SLN status [odds ratio: 3.0 for mixed vs pure, 95 % confidence interval: 1.1-8.7; p < .05]. Completion lymph node dissection was performed in 24 of 28 positive SLN patients with 16.7 % of cases having additional nodal disease. After a median follow-up of 6.3 years, 38 patients developed recurrence and 61 patients died. Positive SLN patients had a significantly higher risk of melanoma-related death compared with negative SLN patients (p = .01)., Conclusions: The overall risk for SLN metastasis for DM is 13.7 % and is significantly higher for mixed (24.6 %) compared with pure (9.0 %) DM. We believe that these rates are sufficient to justify consideration of SLNB for both histologic variants, especially since detection of SLN disease appears to predict a higher risk for melanoma-related death.
- Published
- 2013
- Full Text
- View/download PDF